Skip to main content

Closed

OTLK: Outlook Therapeutics, Inc. Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

25thpctl

Volume

0.37×avg

Market Cap

40.18MUSD

P/E Ratio

-0.7TTM

Div Yield

-ann

Outlook Therapeutics, Inc.

OTLKNASDAQ Capital Market·USD·Closed

Outlook Therapeutics, Inc.

OTLKNASDAQ·USD·Closed

$0.98

−6.10%

$0.98

−$0.06 (6.10%)

52W Range

25thpctl

Volume

0.37×avg

Mkt Cap

40.18MUSD

P/E

-0.7TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings